Astellas Pharma, Inc.AA

Astellas Pharma, Inc.

9.51USDD
+0.10+1.06%
At close at Jul 11, 19:59 GMT
USD
No trades
See on Supercharts
Next report date
July 30
Report period
Q1 2025
EPS estimate
0.12 USD
Revenue estimate
‪3.24 B‬ USD
Market capitalization
‪17.31 B‬USD
0.19USD
‪332.88 M‬USD
‪12.54 B‬USD
‪1.79 B‬
Beta (1Y)
−0.04

About ASTELLAS PHARMA


CEO
Naoki Okamura
Headquarters
Tokyo
Founded
1923
FIGI
BBG000NVS6W6
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Performance
‪−20%‬
‪−10%‬
‪0%‬
‪10%‬
‪20%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−1.20 B‬‬
‪0.00‬
‪‪1.20 B‬‬
‪‪2.40 B‬‬
‪‪3.60 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Jul 30, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−0.40‬
‪−0.20‬
‪0.00‬
‪0.20‬
‪0.40‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.